Viewing Study NCT02358161


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2026-04-18 @ 7:52 PM
Study NCT ID: NCT02358161
Status: COMPLETED
Last Update Posted: 2020-01-09
First Post: 2014-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module